Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice

A. Bartolomucci, A. E. Rigamonti, I. Bulgarelli, A. Torsello, V. Locatelli, F. Pavone, A. Levi, R. Possenti, E. E. Muller, A. Moles

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: Biallelic ablation of VGF determines a dwarf phenotype. VGF precursor protein encodes for different biologically active peptides none of which has been related to growth or muscular abnormalities. Here we present the first attempt to fill this gap. We tested the hypothesis that a recently identified VGF-derived peptide, TLQP-21, shown to centrally modulate metabolic functions, could also modulate growth hormone (GH)-axis and muscle strength. Design: Adult male mice were chronically icv injected with TLQP-21 (15 μg/day for 14 days). Physiological, molecular and behavioral parameters related to the GH/IGF-1-axis were investigated. Results: Except for a reduction in the soleus weight, TLQP-21 did not affect GH/IGF-1-axis mediators, muscle strength and muscle weight. Conclusions: Results collected exclude a role for TLQP-21 in modulating the GH/IGF1-axis and muscle functions. VGF-derived peptides involved in the dwarf phenotype of VGF-/- mice have to be identified yet.

Original languageEnglish
Pages (from-to)342-345
Number of pages4
JournalGrowth Hormone and IGF Research
Volume17
Issue number4
DOIs
Publication statusPublished - Aug 2007

Fingerprint

Muscle Strength
Insulin-Like Growth Factor I
Growth Hormone
Phenotype
Weights and Measures
Muscles
Protein Precursors
Peptides
Growth
VGF peptide

Keywords

  • GH
  • GHRH
  • Grip strength test
  • IGF-1
  • Soleus
  • Somatostatin
  • VGF

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Bartolomucci, A., Rigamonti, A. E., Bulgarelli, I., Torsello, A., Locatelli, V., Pavone, F., ... Moles, A. (2007). Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice. Growth Hormone and IGF Research, 17(4), 342-345. https://doi.org/10.1016/j.ghir.2007.02.002

Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice. / Bartolomucci, A.; Rigamonti, A. E.; Bulgarelli, I.; Torsello, A.; Locatelli, V.; Pavone, F.; Levi, A.; Possenti, R.; Muller, E. E.; Moles, A.

In: Growth Hormone and IGF Research, Vol. 17, No. 4, 08.2007, p. 342-345.

Research output: Contribution to journalArticle

Bartolomucci, A, Rigamonti, AE, Bulgarelli, I, Torsello, A, Locatelli, V, Pavone, F, Levi, A, Possenti, R, Muller, EE & Moles, A 2007, 'Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice', Growth Hormone and IGF Research, vol. 17, no. 4, pp. 342-345. https://doi.org/10.1016/j.ghir.2007.02.002
Bartolomucci, A. ; Rigamonti, A. E. ; Bulgarelli, I. ; Torsello, A. ; Locatelli, V. ; Pavone, F. ; Levi, A. ; Possenti, R. ; Muller, E. E. ; Moles, A. / Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice. In: Growth Hormone and IGF Research. 2007 ; Vol. 17, No. 4. pp. 342-345.
@article{2aae66164e834b24b3ef174d37d51b7e,
title = "Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice",
abstract = "Objective: Biallelic ablation of VGF determines a dwarf phenotype. VGF precursor protein encodes for different biologically active peptides none of which has been related to growth or muscular abnormalities. Here we present the first attempt to fill this gap. We tested the hypothesis that a recently identified VGF-derived peptide, TLQP-21, shown to centrally modulate metabolic functions, could also modulate growth hormone (GH)-axis and muscle strength. Design: Adult male mice were chronically icv injected with TLQP-21 (15 μg/day for 14 days). Physiological, molecular and behavioral parameters related to the GH/IGF-1-axis were investigated. Results: Except for a reduction in the soleus weight, TLQP-21 did not affect GH/IGF-1-axis mediators, muscle strength and muscle weight. Conclusions: Results collected exclude a role for TLQP-21 in modulating the GH/IGF1-axis and muscle functions. VGF-derived peptides involved in the dwarf phenotype of VGF-/- mice have to be identified yet.",
keywords = "GH, GHRH, Grip strength test, IGF-1, Soleus, Somatostatin, VGF",
author = "A. Bartolomucci and Rigamonti, {A. E.} and I. Bulgarelli and A. Torsello and V. Locatelli and F. Pavone and A. Levi and R. Possenti and Muller, {E. E.} and A. Moles",
year = "2007",
month = "8",
doi = "10.1016/j.ghir.2007.02.002",
language = "English",
volume = "17",
pages = "342--345",
journal = "Endocrinology and Metabolism, Supplement",
issn = "1096-6374",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice

AU - Bartolomucci, A.

AU - Rigamonti, A. E.

AU - Bulgarelli, I.

AU - Torsello, A.

AU - Locatelli, V.

AU - Pavone, F.

AU - Levi, A.

AU - Possenti, R.

AU - Muller, E. E.

AU - Moles, A.

PY - 2007/8

Y1 - 2007/8

N2 - Objective: Biallelic ablation of VGF determines a dwarf phenotype. VGF precursor protein encodes for different biologically active peptides none of which has been related to growth or muscular abnormalities. Here we present the first attempt to fill this gap. We tested the hypothesis that a recently identified VGF-derived peptide, TLQP-21, shown to centrally modulate metabolic functions, could also modulate growth hormone (GH)-axis and muscle strength. Design: Adult male mice were chronically icv injected with TLQP-21 (15 μg/day for 14 days). Physiological, molecular and behavioral parameters related to the GH/IGF-1-axis were investigated. Results: Except for a reduction in the soleus weight, TLQP-21 did not affect GH/IGF-1-axis mediators, muscle strength and muscle weight. Conclusions: Results collected exclude a role for TLQP-21 in modulating the GH/IGF1-axis and muscle functions. VGF-derived peptides involved in the dwarf phenotype of VGF-/- mice have to be identified yet.

AB - Objective: Biallelic ablation of VGF determines a dwarf phenotype. VGF precursor protein encodes for different biologically active peptides none of which has been related to growth or muscular abnormalities. Here we present the first attempt to fill this gap. We tested the hypothesis that a recently identified VGF-derived peptide, TLQP-21, shown to centrally modulate metabolic functions, could also modulate growth hormone (GH)-axis and muscle strength. Design: Adult male mice were chronically icv injected with TLQP-21 (15 μg/day for 14 days). Physiological, molecular and behavioral parameters related to the GH/IGF-1-axis were investigated. Results: Except for a reduction in the soleus weight, TLQP-21 did not affect GH/IGF-1-axis mediators, muscle strength and muscle weight. Conclusions: Results collected exclude a role for TLQP-21 in modulating the GH/IGF1-axis and muscle functions. VGF-derived peptides involved in the dwarf phenotype of VGF-/- mice have to be identified yet.

KW - GH

KW - GHRH

KW - Grip strength test

KW - IGF-1

KW - Soleus

KW - Somatostatin

KW - VGF

UR - http://www.scopus.com/inward/record.url?scp=34547477228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547477228&partnerID=8YFLogxK

U2 - 10.1016/j.ghir.2007.02.002

DO - 10.1016/j.ghir.2007.02.002

M3 - Article

VL - 17

SP - 342

EP - 345

JO - Endocrinology and Metabolism, Supplement

JF - Endocrinology and Metabolism, Supplement

SN - 1096-6374

IS - 4

ER -